{"count": 22, "results": [{"_id": "40785326", "pmid": 40785326, "title": "Metformin Treatment in PCOS Pregnancies Reduces Maternal Infections and Increases the Risk of Allergies and Eczema in the Offspring: Post Hoc Analyses of Two Randomised Controlled Trials and One Follow-Up Study.", "journal": "BJOG", "authors": ["Ryssdal M", "Skage JE", "Jarmund AH", "Hanem LGE", "Løvvik TS", "Giskeødegård GF", "Iversen AC", "Vanky E"], "date": "2025-08-11T00:00:00Z", "doi": "10.1111/1471-0528.18320", "meta_date_publication": "2025 Aug 11", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50249.21, "text_hl": "Offspring exposed to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in utero had a higher incidence of @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@allergies@@@ (OR = 4.83, 95% CI: 1.47-21.8) and @DISEASE_Eczema @DISEASE_MESH:D004485 @@@eczema@@@ (OR = 2.42, 95% CI: 1.14-5.33). ", "citations": {"NLM": "Ryssdal M, Skage JE, Jarmund AH, Hanem LGE, Løvvik TS, Giskeødegård GF, Iversen AC, Vanky E. Metformin Treatment in PCOS Pregnancies Reduces Maternal Infections and Increases the Risk of Allergies and Eczema in the Offspring: Post Hoc Analyses of Two Randomised Controlled Trials and One Follow-Up Study. BJOG. 2025 Aug 11;():. PMID: 40785326", "BibTeX": "@article{40785326, title={Metformin Treatment in PCOS Pregnancies Reduces Maternal Infections and Increases the Risk of Allergies and Eczema in the Offspring: Post Hoc Analyses of Two Randomised Controlled Trials and One Follow-Up Study.}, author={Ryssdal M and Skage JE and Jarmund AH and Hanem LGE and Løvvik TS and Giskeødegård GF and Iversen AC and Vanky E}, journal={BJOG}}"}}, {"_id": "37606429", "pmid": 37606429, "pmcid": "PMC10443323", "title": "Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients", "journal": "Med Sci (Basel)", "authors": ["Susilawati E", "Levita J", "Susilawati Y", "Sumiwi SA"], "date": "2023-08-15T00:00:00Z", "doi": "10.3390/medsci11030050", "meta_date_publication": "2023 Aug 15", "meta_volume": "11", "meta_issue": "3", "meta_pages": "", "score": 50249.113, "text_hl": "...4. Pharmacology of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@", "citations": {"NLM": "Susilawati E, Levita J, Susilawati Y, Sumiwi SA. Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients Med Sci (Basel). 2023 Aug 15;11(3):. PMID: 37606429", "BibTeX": "@article{37606429, title={Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients}, author={Susilawati E and Levita J and Susilawati Y and Sumiwi SA}, journal={Med Sci (Basel)}, volume={11}, number={3}}"}}, {"_id": "37924435", "pmid": 37924435, "title": "Effect of Metformin on Epidermal Neural Crest Stem Cells and Their Potential Application in Ameliorating Paclitaxel-induced Neurotoxicity Phenotype.", "journal": "Stem Cell Rev Rep", "authors": ["Khodabakhsh P", "Asgari Taei A", "Shafaroodi H", "Pournajaf S", "Dargahi L"], "date": "2023-11-04T00:00:00Z", "doi": "10.1007/s12015-023-10642-x", "meta_date_publication": "2023 Nov 4", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50239.39, "text_hl": "Further, it was observed that intranasal @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated EPI-NCSCs improved the @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@cognitive impairment@@@, and @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@mechanical and thermal hypersensitivity@@@ induced by @CHEMICAL_Paclitaxel @CHEMICAL_MESH:D017239 @@@paclitaxel@@@ in rats. ", "citations": {"NLM": "Khodabakhsh P, Asgari Taei A, Shafaroodi H, Pournajaf S, Dargahi L. Effect of Metformin on Epidermal Neural Crest Stem Cells and Their Potential Application in Ameliorating Paclitaxel-induced Neurotoxicity Phenotype. Stem Cell Rev Rep. 2023 Nov 4;():. PMID: 37924435", "BibTeX": "@article{37924435, title={Effect of Metformin on Epidermal Neural Crest Stem Cells and Their Potential Application in Ameliorating Paclitaxel-induced Neurotoxicity Phenotype.}, author={Khodabakhsh P and Asgari Taei A and Shafaroodi H and Pournajaf S and Dargahi L}, journal={Stem Cell Rev Rep}}"}}, {"_id": "35732105", "pmid": 35732105, "title": "Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS.", "journal": "J Chromatogr B Analyt Technol Biomed Life Sci", "authors": ["Wegler C", "Saleh A", "Lindqvist A", "Nordeng H", "Smeraglia J", "Baranczewski P"], "date": "2022-08-01T00:00:00Z", "doi": "10.1016/j.jchromb.2022.123340", "meta_date_publication": "2022 Aug 1", "meta_volume": "1205", "meta_issue": "", "meta_pages": "123340", "score": 50239.207, "text_hl": "Complications such as @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@allergies@@@, @DISEASE_Depression_Postpartum @DISEASE_MESH:D019052 @@@postpartum depression@@@, and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ are often treated with drugs such as @CHEMICAL_Cetirizine @CHEMICAL_MESH:D017332 @@@cetirizine@@@, @CHEMICAL_Venlafaxine_Hydrochloride @CHEMICAL_MESH:D000069470 @@@venlafaxine@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, respectively. ", "citations": {"NLM": "Wegler C, Saleh A, Lindqvist A, Nordeng H, Smeraglia J, Baranczewski P. Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Aug 1;1205():123340. PMID: 35732105", "BibTeX": "@article{35732105, title={Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS.}, author={Wegler C and Saleh A and Lindqvist A and Nordeng H and Smeraglia J and Baranczewski P}, journal={J Chromatogr B Analyt Technol Biomed Life Sci}, volume={1205}, pages={123340}}"}}, {"_id": "35278160", "pmid": 35278160, "title": "Metformin Relieves Bortezomib-Induced Neuropathic Pain by Regulating AMPKa2-Mediated Autophagy in the Spinal Dorsal Horn.", "journal": "Neurochem Res", "authors": ["Liu M", "Zhao YT", "Lv YY", "Xu T", "Li D", "Xiong YC", "Xin WJ", "Lin SY"], "date": "2022-07-01T00:00:00Z", "doi": "10.1007/s11064-022-03571-7", "meta_date_publication": "2022 Jul", "meta_volume": "47", "meta_issue": "7", "meta_pages": "1878-1887", "score": 50238.61, "text_hl": "Our findings suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may regulate @GENE_PRKAA2 @GENE_78975 @@@AMPKa2@@@-mediated autophagy in the dorsal horn and alleviate the behavioral @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@hypersensitivity@@@ induced by @CHEMICAL_Bortezomib @CHEMICAL_MESH:D000069286 @@@BTZ@@@.", "citations": {"NLM": "Liu M, Zhao YT, Lv YY, Xu T, Li D, Xiong YC, Xin WJ, Lin SY. Metformin Relieves Bortezomib-Induced Neuropathic Pain by Regulating AMPKa2-Mediated Autophagy in the Spinal Dorsal Horn. Neurochem Res. 2022 Jul;47(7):1878-1887. PMID: 35278160", "BibTeX": "@article{35278160, title={Metformin Relieves Bortezomib-Induced Neuropathic Pain by Regulating AMPKa2-Mediated Autophagy in the Spinal Dorsal Horn.}, author={Liu M and Zhao YT and Lv YY and Xu T and Li D and Xiong YC and Xin WJ and Lin SY}, journal={Neurochem Res}, volume={47}, number={7}, pages={1878-1887}}"}}, {"_id": "31874168", "pmid": 31874168, "title": "Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice.", "journal": "Neuropharmacology", "authors": ["Xing X", "Wu K", "Dong Y", "Zhou Y", "Zhang J", "Jiang F", "Hu WP", "Li JD"], "date": "2020-03-15T00:00:00Z", "doi": "10.1016/j.neuropharm.2019.107816", "meta_date_publication": "2020 Mar 15", "meta_volume": "165", "meta_issue": "", "meta_pages": "107816", "score": 50235.754, "text_hl": "We further indicated that treatment with the FDA-approved drug @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ normalized the hyperactive @GENE_AKT1 @GENE_11651 @@@Akt@@@-@GENE_MTOR @GENE_56717 @@@mTOR@@@ signaling, and attenuated @DISEASE_Pain @DISEASE_MESH:D010146 @@@pain@@@-related @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@hypersensitivity@@@ in @GENE_CNTNAP2 @GENE_66797 @@@Cntnap2@@@-/- @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Xing X, Wu K, Dong Y, Zhou Y, Zhang J, Jiang F, Hu WP, Li JD. Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice. Neuropharmacology. 2020 Mar 15;165():107816. PMID: 31874168", "BibTeX": "@article{31874168, title={Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice.}, author={Xing X and Wu K and Dong Y and Zhou Y and Zhang J and Jiang F and Hu WP and Li JD}, journal={Neuropharmacology}, volume={165}, pages={107816}}"}}, {"_id": "21572665", "pmid": 21572665, "pmcid": "PMC3081469", "title": "Metformin allergy", "journal": "Indian J Pharmacol", "authors": ["Wiwanitkit V"], "date": "2011-04-01T00:00:00Z", "doi": "10.4103/0253-7613.77379", "meta_date_publication": "2011 Apr", "meta_volume": "43", "meta_issue": "2", "meta_pages": "216-7", "score": 50083.336, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@allergy@@@", "citations": {"NLM": "Wiwanitkit V. Metformin allergy Indian J Pharmacol. 2011 Apr;43(2):216-7. PMID: 21572665", "BibTeX": "@article{21572665, title={Metformin allergy}, author={Wiwanitkit V}, journal={Indian J Pharmacol}, volume={43}, number={2}, pages={216-7}}"}}, {"_id": "24417956", "pmid": 24417956, "title": "Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation.", "journal": "Diabetes Metab", "authors": ["Lalau JD", "Azzoug ML", "Kajbaf F", "Briet C", "Desailloud R"], "date": "2014-06-01T00:00:00Z", "doi": "10.1016/j.diabet.2013.12.003", "meta_date_publication": "2014 Jun", "meta_volume": "40", "meta_issue": "3", "meta_pages": "220-3", "score": 50066.74, "text_hl": "CONCLUSION: These clinical data suggest a new concept for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy: there may be either resistance or, conversely, @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@hypersensitivity@@@ to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ effects on @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@ generation according to the individual @SPECIES_9606 @@@patient@@@.", "citations": {"NLM": "Lalau JD, Azzoug ML, Kajbaf F, Briet C, Desailloud R. Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation. Diabetes Metab. 2014 Jun;40(3):220-3. PMID: 24417956", "BibTeX": "@article{24417956, title={Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation.}, author={Lalau JD and Azzoug ML and Kajbaf F and Briet C and Desailloud R}, journal={Diabetes Metab}, volume={40}, number={3}, pages={220-3}}"}}, {"_id": "7073794", "pmid": 7073794, "title": "Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits.", "journal": "Atherosclerosis", "authors": ["Tremoli E", "Ghiselli G", "Maderna P", "Colli S", "Sirtori CR"], "date": "1982-01-01T00:00:00Z", "doi": "10.1016/0021-9150(82)90069-7", "meta_date_publication": "1982 Jan", "meta_volume": "41", "meta_issue": "1", "meta_pages": "53-60", "score": 50064.555, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduces @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@platelet hypersensitivity@@@ in @DISEASE_Hyperlipoproteinemia_Type_II @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ @SPECIES_9986 @@@rabbits@@@.", "citations": {"NLM": "Tremoli E, Ghiselli G, Maderna P, Colli S, Sirtori CR. Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits. Atherosclerosis. 1982 Jan;41(1):53-60. PMID: 7073794", "BibTeX": "@article{7073794, title={Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits.}, author={Tremoli E and Ghiselli G and Maderna P and Colli S and Sirtori CR}, journal={Atherosclerosis}, volume={41}, number={1}, pages={53-60}}"}}, {"_id": "27548055", "pmid": 27548055, "title": "Metformin-Induced Type 1 Hypersensitivity in a Child with Antipsychotic-Induced Weight Gain.", "journal": "J Child Adolesc Psychopharmacol", "authors": ["Mennella C", "Dickstein DP"], "date": "2017-02-01T00:00:00Z", "doi": "10.1089/cap.2016.0113", "meta_date_publication": "2017 Feb", "meta_volume": "27", "meta_issue": "1", "meta_pages": "106-107", "score": 50062.54, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-Induced @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@Type 1 Hypersensitivity@@@ in a Child with Antipsychotic-Induced Weight Gain.", "citations": {"NLM": "Mennella C, Dickstein DP. Metformin-Induced Type 1 Hypersensitivity in a Child with Antipsychotic-Induced Weight Gain. J Child Adolesc Psychopharmacol. 2017 Feb;27(1):106-107. PMID: 27548055", "BibTeX": "@article{27548055, title={Metformin-Induced Type 1 Hypersensitivity in a Child with Antipsychotic-Induced Weight Gain.}, author={Mennella C and Dickstein DP}, journal={J Child Adolesc Psychopharmacol}, volume={27}, number={1}, pages={106-107}}"}}]}